319 related articles for article (PubMed ID: 27197287)
21. Toenail selenium, plasma selenoprotein P and risk of advanced prostate cancer: A nested case-control study.
Outzen M; Tjønneland A; Hughes DJ; Jenab M; Frederiksen K; Schomburg L; Morris S; Overvad K; Olsen A
Int J Cancer; 2021 Feb; 148(4):876-883. PubMed ID: 32838475
[TBL] [Abstract][Full Text] [Related]
22. Vitamin D in blood and risk of prostate cancer: lessons from the Selenium and Vitamin E Cancer Prevention Trial and the Prostate Cancer Prevention Trial.
Schwartz GG
Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1447-9. PubMed ID: 25085835
[TBL] [Abstract][Full Text] [Related]
23. Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
Brasky TM; Darke AK; Song X; Tangen CM; Goodman PJ; Thompson IM; Meyskens FL; Goodman GE; Minasian LM; Parnes HL; Klein EA; Kristal AR
J Natl Cancer Inst; 2013 Aug; 105(15):1132-41. PubMed ID: 23843441
[TBL] [Abstract][Full Text] [Related]
24. Selenium and vitamin E supplements for prostate cancer: evidence or embellishment?
Moyad MA
Urology; 2002 Apr; 59(4 Suppl 1):9-19. PubMed ID: 11937432
[TBL] [Abstract][Full Text] [Related]
25. Single-nucleotide polymorphisms within the antioxidant defence system and associations with aggressive prostate cancer.
Abe M; Xie W; Regan MM; King IB; Stampfer MJ; Kantoff PW; Oh WK; Chan JM
BJU Int; 2011 Jan; 107(1):126-34. PubMed ID: 20477822
[TBL] [Abstract][Full Text] [Related]
26. Oxidative stress-related genetic variants, pro- and antioxidant intake and status, and advanced prostate cancer risk.
Geybels MS; van den Brandt PA; van Schooten FJ; Verhage BA
Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):178-86. PubMed ID: 25315963
[TBL] [Abstract][Full Text] [Related]
27. Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.
Winchester DA; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Xu J; Zheng SL; Thompson IM; Lucia MS; Lippmann SM; Parnes HL; Dluzniewski PJ; Isaacs WB; De Marzo AM; Drake CG; Platz EA
Prostate; 2015 Sep; 75(13):1403-18. PubMed ID: 26047319
[TBL] [Abstract][Full Text] [Related]
28. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Klein EA; Thompson IM; Tangen CM; Crowley JJ; Lucia MS; Goodman PJ; Minasian LM; Ford LG; Parnes HL; Gaziano JM; Karp DD; Lieber MM; Walther PJ; Klotz L; Parsons JK; Chin JL; Darke AK; Lippman SM; Goodman GE; Meyskens FL; Baker LH
JAMA; 2011 Oct; 306(14):1549-56. PubMed ID: 21990298
[TBL] [Abstract][Full Text] [Related]
29. Interaction of NKX3.1 and SELENOP genotype with prostate cancer recurrence.
Donadio JLS; Liu L; Freeman VL; Ekoue DN; Diamond AM; Bermano G
Prostate; 2019 Apr; 79(5):462-467. PubMed ID: 30582190
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms in thioredoxin reductase and selenoprotein K genes and selenium status modulate risk of prostate cancer.
Méplan C; Rohrmann S; Steinbrecher A; Schomburg L; Jansen E; Linseisen J; Hesketh J
PLoS One; 2012; 7(11):e48709. PubMed ID: 23133653
[TBL] [Abstract][Full Text] [Related]
31. The association between baseline vitamin E, selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention study.
Hartman TJ; Albanes D; Pietinen P; Hartman AM; Rautalahti M; Tangrea JA; Taylor PR
Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):335-40. PubMed ID: 9568790
[TBL] [Abstract][Full Text] [Related]
32. A Prospective Study of Chronic Inflammation in Benign Prostate Tissue and Risk of Prostate Cancer: Linked PCPT and SELECT Cohorts.
Platz EA; Kulac I; Barber JR; Drake CG; Joshu CE; Nelson WG; Lucia MS; Klein EA; Lippman SM; Parnes HL; Thompson IM; Goodman PJ; Tangen CM; De Marzo AM
Cancer Epidemiol Biomarkers Prev; 2017 Oct; 26(10):1549-1557. PubMed ID: 28754796
[No Abstract] [Full Text] [Related]
33. Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer.
Tsavachidou D; McDonnell TJ; Wen S; Wang X; Vakar-Lopez F; Pisters LL; Pettaway CA; Wood CG; Do KA; Thall PF; Stephens C; Efstathiou E; Taylor R; Menter DG; Troncoso P; Lippman SM; Logothetis CJ; Kim J
J Natl Cancer Inst; 2009 Mar; 101(5):306-20. PubMed ID: 19244175
[TBL] [Abstract][Full Text] [Related]
34. SELECT: the next prostate cancer prevention trial. Selenum and Vitamin E Cancer Prevention Trial.
Klein EA; Thompson IM; Lippman SM; Goodman PJ; Albanes D; Taylor PR; Coltman C
J Urol; 2001 Oct; 166(4):1311-5. PubMed ID: 11547064
[TBL] [Abstract][Full Text] [Related]
35. Clinical models for testing chemopreventative agents in prostate cancer and overview of SELECT: the Selenium and Vitamin E Cancer Prevention Trial.
Klein EA
Recent Results Cancer Res; 2003; 163():212-25; discussion 264-6. PubMed ID: 12903856
[TBL] [Abstract][Full Text] [Related]
36. Moving a randomized clinical trial into an observational cohort.
Goodman PJ; Hartline JA; Tangen CM; Crowley JJ; Minasian LM; Klein EA; Cook ED; Darke AK; Arnold KB; Anderson K; Yee M; Meyskens FL; Baker LH
Clin Trials; 2013 Feb; 10(1):131-42. PubMed ID: 23064404
[TBL] [Abstract][Full Text] [Related]
37. The selenium and vitamin E cancer prevention trial.
Klein EA; Lippman SM; Thompson IM; Goodman PJ; Albanes D; Taylor PR; Coltman C
World J Urol; 2003 May; 21(1):21-7. PubMed ID: 12756490
[TBL] [Abstract][Full Text] [Related]
38. Circulating Selenium and Prostate Cancer Risk: A Mendelian Randomization Analysis.
Yarmolinsky J; Bonilla C; Haycock PC; Langdon RJQ; Lotta LA; Langenberg C; Relton CL; Lewis SJ; Evans DM; ; Davey Smith G; Martin RM
J Natl Cancer Inst; 2018 Sep; 110(9):1035-1038. PubMed ID: 29788239
[TBL] [Abstract][Full Text] [Related]
39. Age-related cataract in men in the selenium and vitamin e cancer prevention trial eye endpoints study: a randomized clinical trial.
Christen WG; Glynn RJ; Gaziano JM; Darke AK; Crowley JJ; Goodman PJ; Lippman SM; Lad TE; Bearden JD; Goodman GE; Minasian LM; Thompson IM; Blanke CD; Klein EA
JAMA Ophthalmol; 2015 Jan; 133(1):17-24. PubMed ID: 25232809
[TBL] [Abstract][Full Text] [Related]
40. Genetic variants reflecting higher vitamin e status in men are associated with reduced risk of prostate cancer.
Major JM; Yu K; Weinstein SJ; Berndt SI; Hyland PL; Yeager M; Chanock S; Albanes D
J Nutr; 2014 May; 144(5):729-33. PubMed ID: 24623848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
